Hong Kong Biotech Firm Soars on IPO Debut with AI-Powered Drug Delivery
METiS TechBio, an AI-driven drug design startup, saw its shares surge 173% on its Hong Kong debut, driven by strong investor demand for AI-related stocks. The company utilizes artificial intelligence to develop nano-rockets for drug delivery.